Biden and Trump are fighting to claim credit for $35 insulin. It was actually a pharma giant’s idea

WASHINGTON — Both President Biden and former President Trump love to claim credit for getting more Americans $35 insulin.

But the credit should actually go to a giant pharmaceutical company — just the type that both men claim to have challenged.

Eli Lilly, an $800 billion pharma giant and one of three insulin manufacturers in the United States, first proposed an experiment allowing Medicare insurance plans to offer $35 monthly insulin in 2019, CEO David Ricks and former Medicare agency chief Seema Verma said in interviews with STAT.

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Argenx rolls out new campaign for rare autoimmune condition as it awaits FDA ruling

Argenx is taking a page from its own commercialization playbook with a new rare disease campaign. The unbranded “Shining through CIDP” campaign showcases real stories

February 29, 2024

Northwestern Medicine Residents Latest to Seek Union Status

Residents and fellows at Northwestern Medicine in Chicago are the latest group of young doctors trying to form a union. The group, comprised of nearly

December 5, 2023

DrFirst and PatchRx Partner to Combat Medication Non-Adherence

What You Should Know: – Healthcare technology leader DrFirst has joined forces with medication adherence company PatchRx to tackle a major healthcare challenge: medication non-adherence.

April 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.